About six months after coming out of stealth with $50 million in funding, Latent Labs has released a web-based AI model for ...

Demis Hassabis, the cofounder and CEO of DeepMind, is one of three researchers to be awarded the Nobel Prize in chemistry.

CASP, the protein structure prediction contest that launched DeepMind’s AlphaFold to international fame and a Nobel Prize, ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Google’s GNoME AI might be the most important scientific discovery tool since AlphaFold. By identifying novel, stable ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

AlphaFold, an AI from DeepMind, may have an answer. It can predict, with heretofore unseen accuracy, the shape a protein will take. AlphaFold was put to the test in a global competition called ...

AlphaFold’s strategy is similar to most entries in CASP this year, in that it relies on deep learning. Remember: amino acid sequences, the building blocks of proteins, contain data about a protein’s ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Researchers used AlphaFold and homology modeling to identify potent TAAR1 agonists, showing AlphaFold's superior performance in drug discovery for neuropsychiatric conditions.